Myelofibrosis Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H2, 2012' provides data on the Myelofibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myelofibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myelofibrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Reasons to buy
Keywords
Myelofibrosis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Myelofibrosis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Summary
GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H2, 2012' provides data on the Myelofibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myelofibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myelofibrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Myelofibrosis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Myelofibrosis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Introduction
Myelofibrosis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Myelofibrosis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Myelofibrosis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Incyte Corporation
Clinical Trial Overview of Incyte Corporation
Novartis AG
Clinical Trial Overview of Novartis AG
S*BIO Pte Ltd
Clinical Trial Overview of S*BIO Pte Ltd
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Sanofi
Clinical Trial Overview of Sanofi
YM BioSciences Inc.
Clinical Trial Overview of YM BioSciences Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Astex Therapeutics Limited
Clinical Trial Overview of Astex Therapeutics Limited
TargeGen, Inc.
Clinical Trial Overview of TargeGen, Inc.
NS Pharma, Inc.
Clinical Trial Overview of NS Pharma, Inc.
U.S. Biotest Inc.
Clinical Trial Overview of U.S. Biotest Inc.
Pharma Mar, S.A.
Clinical Trial Overview of Pharma Mar, S.A.
Threshold Pharmaceuticals, Inc.
Clinical Trial Overview of Threshold Pharmaceuticals, Inc.
Luitpold Pharmaceuticals, Inc.
Clinical Trial Overview of Luitpold Pharmaceuticals, Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Myeloproliferative Disorders-Research Consortium
Clinical Trial Overview of Myeloproliferative Disorders-Research Consortium
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
The University of Utah
Clinical Trial Overview of The University of Utah
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Mount Sinai School of Medicine
Clinical Trial Overview of Mount Sinai School of Medicine
Medisch Spectrum Twente
Clinical Trial Overview of Medisch Spectrum Twente
Singapore General Hospital
Clinical Trial Overview of Singapore General Hospital
St Vincent's Hospital Sydney
Clinical Trial Overview of St Vincent's Hospital Sydney
University Hospital Gasthuisberg
Clinical Trial Overview of University Hospital Gasthuisberg
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Odense University Hospital
Clinical Trial Overview of Odense University Hospital
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Duke University
Clinical Trial Overview of Duke University
University of Illinois
Clinical Trial Overview of University of Illinois
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, North America, Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, BRIC Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, G7 Countries, 2012*
Myelofibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Clinical Trials, E7 Countries, 2012*
Myelofibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Myelofibrosis Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Myelofibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by S*BIO Pte Ltd, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by YM BioSciences Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astex Therapeutics Limited, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by TargeGen, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by NS Pharma, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Biotest Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharma Mar, S.A., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Threshold Pharmaceuticals, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Luitpold Pharmaceuticals, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Myeloproliferative Disorders-Research Consortium, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medisch Spectrum Twente, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St Vincent's Hospital Sydney, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Gasthuisberg, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2012*
LIST OF FIGURES
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, G7 Countries (%), 2012*
Myelofibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Clinical Trials, E7 Countries (%), 2012*
Myelofibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Myelofibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
Myelofibrosis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Myelofibrosis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Myelofibrosis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Incyte Corporation
Clinical Trial Overview of Incyte Corporation
Novartis AG
Clinical Trial Overview of Novartis AG
S*BIO Pte Ltd
Clinical Trial Overview of S*BIO Pte Ltd
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Sanofi
Clinical Trial Overview of Sanofi
YM BioSciences Inc.
Clinical Trial Overview of YM BioSciences Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Astex Therapeutics Limited
Clinical Trial Overview of Astex Therapeutics Limited
TargeGen, Inc.
Clinical Trial Overview of TargeGen, Inc.
NS Pharma, Inc.
Clinical Trial Overview of NS Pharma, Inc.
U.S. Biotest Inc.
Clinical Trial Overview of U.S. Biotest Inc.
Pharma Mar, S.A.
Clinical Trial Overview of Pharma Mar, S.A.
Threshold Pharmaceuticals, Inc.
Clinical Trial Overview of Threshold Pharmaceuticals, Inc.
Luitpold Pharmaceuticals, Inc.
Clinical Trial Overview of Luitpold Pharmaceuticals, Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Myeloproliferative Disorders-Research Consortium
Clinical Trial Overview of Myeloproliferative Disorders-Research Consortium
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
The University of Utah
Clinical Trial Overview of The University of Utah
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Mount Sinai School of Medicine
Clinical Trial Overview of Mount Sinai School of Medicine
Medisch Spectrum Twente
Clinical Trial Overview of Medisch Spectrum Twente
Singapore General Hospital
Clinical Trial Overview of Singapore General Hospital
St Vincent's Hospital Sydney
Clinical Trial Overview of St Vincent's Hospital Sydney
University Hospital Gasthuisberg
Clinical Trial Overview of University Hospital Gasthuisberg
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Odense University Hospital
Clinical Trial Overview of Odense University Hospital
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Duke University
Clinical Trial Overview of Duke University
University of Illinois
Clinical Trial Overview of University of Illinois
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, North America, Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, BRIC Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, G7 Countries, 2012*
Myelofibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Clinical Trials, E7 Countries, 2012*
Myelofibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Myelofibrosis Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Myelofibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by S*BIO Pte Ltd, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by YM BioSciences Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astex Therapeutics Limited, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by TargeGen, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by NS Pharma, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Biotest Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharma Mar, S.A., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Threshold Pharmaceuticals, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Luitpold Pharmaceuticals, Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Myeloproliferative Disorders-Research Consortium, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medisch Spectrum Twente, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St Vincent's Hospital Sydney, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Gasthuisberg, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Myelofibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2012*
LIST OF FIGURES
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Myelofibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Myelofibrosis Therapeutics Clinical Trials, G7 Countries (%), 2012*
Myelofibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Clinical Trials, E7 Countries (%), 2012*
Myelofibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Myelofibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Myelofibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Myelofibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
